InventisBio Co., Limited (SHA:688382)
China
· Delayed Price · Currency is CNY 22.19
-0.76 (-3.31%)
At close: Apr 28, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 12.83 billion as of April 28, 2026. Its market cap has increased by 16.24% in one year.
Market Cap
12.83B
Enterprise Value
11.32B
Revenue
37.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.19
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 12.83B, an increase of 45.97%. That is a compound annual growth rate of 10.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 12.83B | -18.54% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 12.88B |
| Staidson (Beijing) BioPharmaceuticals | 13.19B |
| Inner Mongolia Furui Medical Science | 13.77B |
| Vcanbio Cell & Gene Engineering Corp., | 11.92B |
| Pacific Shuanglin Bio-pharmacy | 11.67B |
| Hualan Biological Vaccine | 11.46B |
| Chengdu Olymvax Biopharmaceuticals | 11.35B |
| Chongqing Genrix Biopharmaceutical | 11.29B |